Bridging the Gap in Chronic Prurigo Care: Evidence-Based Diagnostic and Therapeutic Recommendations from a Delphi Consensus Panel. [PDF]
Dermatol Ther (Heidelb)Mendes-Bastos P +5 more
europepmc +1 more source
Real-world Clinical Efficacy and Patient-reported Treatment Satisfaction of Nemolizumab Treatment in Prurigo Nodularis. [PDF]
Acta Derm VenereolMima Y, Yamamoto M, Iozumi K.
europepmc +1 more source
Ivarmacitinib in atopic dermatitis presenting with prurigo nodularis-like lesions and alopecia areata: a case report. [PDF]
Front ImmunolLiao X, Lu Y.
europepmc +1 more source
Beyond Histamine: Mast Cell-Neuron Communication in Chronic Pruritic and Pain Disorders. [PDF]
Exp DermatolKagan T, Yosipovitch G.
europepmc +1 more source
Safety, Pharmacokinetics, and Efficacy of 1.5% Ruxolitinib Gel (HDM3010) in Adult Patients with Prurigo Nodularis: A Phase I/II, Randomized, Double-Blind, Vehicle-Controlled Multicenter Clinical Trial. [PDF]
Dermatol Ther (Heidelb)Wu C +28 more
europepmc +1 more source
In 1971, 20 cases of prurigo pigmentosa, as a clinical entity, were reported by Nagashima and 60 cases in total have been found in Japan. No cases have been reportd in other countries. The disease is not well known in etiology.
Nakama, Takeo +3 more
core
Dupilumab Improves Prurigo Activity and Severity in Patients with Prurigo Nodularis: A Post Hoc Analysis of Pooled Results from the PRIME and PRIME2 Trials. [PDF]
Dermatol Ther (Heidelb)Stander S +8 more
europepmc +1 more source
Prurigo Nodularis in Lepromatous Leprosy: A Manifestation of Neuropathic Pruritus and Denervation Dermatopathy. [PDF]
Indian Dermatol Online JSharma A, Chatterjee D, Narang T.
europepmc +1 more source
Atypical Prurigo Pigmentosa Following Ketogenic Diet: Successful Treatment with Doxycycline and Tofacitinib. [PDF]
Acta Derm VenereolZhang X, Bu Z.
europepmc +1 more source
Dupilumab Treatment Provides Multidimensional Benefits in Patients with Prurigo Nodularis. [PDF]
Dermatol Ther (Heidelb)Ständer S +8 more
europepmc +1 more source